GCC-investor Amanat Holdings has sold its 13% stake in hospital International Medical Centre, a month after CEO Mohamad Hamade told HBI that it was shifting its strategy towards majority investments.
Strong rumours reported by HBI back in July that Nordic Capital-backed ophthalmology group Veonet (including Germany's largest operator by revenue Ober Scharrer) would come to market before the autumn have been proven correct. HBI understands the group has launched a process, and a price tag of in excess of €2bn is expected.
German lab group amedes is selling to a consortium including Canada's OMERS Infrastructure, Goldman Sachs Asset Management, and asset manager AXA Investment Managers.
Pan-European dental group Curaeos has been sold by EQT and minority stakeholders to family-owned Colosseum Dental Group, creating Europe's largest dental group by revenue. HBI speaks to a Europe-based operator to find out more.
UK-based NHS dental specialist IDH, which operates over 600 UK-based clinics as {my}dentist and supplies thousands of dentists with products and equipment through dental supplier DD, is for sale. Could the group could be broken up if the buyer for the whole is not found?
HBI hears that Dutch and Nordic ambulatory and ophthalmology clinic chain Bergman Clinic is looking to acquire two substantial outpatient ophthalmology chains in Germany. This would mark its entry into the country’s ophthalmology market – and a significant one at that. We talk to a source about the targets, the price, and what this means for the wider market. Longer-term Bergman itself is likely to sell.
European-focused PE firm Nordic Capital is reportedly buying SpaMedica, the UK's largest cataract surgery provider, in a deal that values the ophthalmic group at around £300m.
HBI understands that a majority stake is being sold by a fast-growing UK-based dental chain to a European PE fund. We name the group, buyer, price and multiple, and speak to a market expert about the deal.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
